Package 69097-840-64

{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "14b7dfcc-b3a8-4027-9544-8d52ec2aacf3", "openfda": {"unii": ["021SEF3731", "J697UZ2A9J"], "rxcui": ["1437702"], "spl_set_id": ["89d59bd9-c826-413c-8ed9-a1521a0c7cc5"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (69097-840-53)  / 1 VIAL in 1 POUCH (69097-840-34)  / 3 mL in 1 VIAL", "package_ndc": "69097-840-53", "marketing_start_date": "20200601"}, {"sample": false, "description": "2 POUCH in 1 CARTON (69097-840-64)  / 30 VIAL in 1 POUCH / 3 mL in 1 VIAL", "package_ndc": "69097-840-64", "marketing_start_date": "20200601"}, {"sample": false, "description": "1 POUCH in 1 CARTON (69097-840-87)  / 30 VIAL in 1 POUCH / 3 mL in 1 VIAL", "package_ndc": "69097-840-87", "marketing_start_date": "20200601"}], "brand_name": "Ipratropium Bromide and Albuterol Sulfate", "product_id": "69097-840_14b7dfcc-b3a8-4027-9544-8d52ec2aacf3", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "69097-840", "generic_name": "Ipratropium Bromide and Albuterol Sulfate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ipratropium Bromide and Albuterol Sulfate", "active_ingredients": [{"name": "ALBUTEROL SULFATE", "strength": "2.5 mg/3mL"}, {"name": "IPRATROPIUM BROMIDE", "strength": ".5 mg/3mL"}], "application_number": "ANDA202496", "marketing_category": "ANDA", "marketing_start_date": "20200601", "listing_expiration_date": "20261231"}